A review of factors influencing vaccination policies and programs for older adults globally

Hum Vaccin Immunother. 2023 Dec 31;19(1):2157164. doi: 10.1080/21645515.2022.2157164. Epub 2023 Jan 19.

Abstract

Policies and programs to increase vaccine coverage rates among adults 50 years of age or older are limited and vaccine uptake is often suboptimal. Our review evaluated evidence on the effectiveness and success of adult-targeted vaccination interventions and identified literature gaps. Literature was retrieved (2021) from PubMed, Embase, and Google Scholar databases. Outcomes assessed included data on an intervention's effectiveness and impact on vaccine uptake. Interventions were characterized thematically: affordability (n = 9), awareness (n = 25), and vaccination access (n = 6); and included influenza, pneumococcal, tetanus-containing, and herpes zoster vaccines. Interactive interventions directed toward patients, including provider-led educational initiatives and provider recommendations showed more positive associations than less interactive interventions, such as posters and reminder-recall letters. Provider interventions, including awareness campaigns, incentives, affordability efforts, or vaccination site expansion generally showed positive associations. Combining interventions was found to be successful across several studies. Barriers and interventions varied for population subgroups, therefore, tailoring programs is critical.

Keywords: Older adults; evidence-based; intervention; policy; routine adult vaccination; vaccination program.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Humans
  • Immunization Programs
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Pneumococcal Vaccines
  • Policy
  • Vaccination

Substances

  • Influenza Vaccines
  • Pneumococcal Vaccines

Grants and funding

This work was funded by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.